NovoTwist® 5 mm needles significantly reduce the risk of intramuscular injection
Superflow™ and Thin Wall technologies are designed to improve insulin flow, reducing injection time and force
APROM ID# 3125. June 2011.
Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 32,500 employees in 74 countries, and markets its products in 179 countries.
 | Novo Nordisk in the USA |
 | Novo Nordisk in Denmark |
Or choose:
